Sandbox ID Gastrointestinal and Intraabdominal: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 14: | Line 14: | ||
====Immunocompetent==== | ====Immunocompetent==== | ||
:* Shigella species: | :* Shigella species: | ||
::*Adult dose: [[TMP-SMZ]], 160 and 800 mg, respectively b.i.d. x 3 d (if susceptible ) {{or}} [[ | ::*Preferred regimen: | ||
::*Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. x 3 d | :::*Adult dose: [[TMP-SMZ]], 160 and 800 mg, respectively b.i.d. x 3 d (if susceptible ) {{or}} [[fluoroquinolone]] (e.g., 300 mg [[ofloxacin]], 400 mg [[norfloxacin]], {{or}} 500 mg [[ciprofloxacin]] b.i.d. x 3 d) | ||
:::*Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. x 3 d | |||
:* Alternative regimen: [[DrugName]] Dosage_Duration | :* Alternative regimen: [[DrugName]] Dosage_Duration |
Revision as of 18:30, 28 May 2015
Gastrointestinal anthrax
- Gastrointestinal anthrax
- Preferred regimen: Ciprofloxacin 400 mg intravenously every 8 h OR doxycycline 100 mg intravenously every 12 h combined with second agent: clindamycin 600 mg intravenously every 8 h or penicillin G 4 MU every 4–6 h OR meropenem 1 gm intravenously every 6–8 h or rifampin 300 mg every 12 h.
Infectious diarrhea
- Infectious diarrhea
Immunocompetent
- Shigella species:
- Preferred regimen:
- Adult dose: TMP-SMZ, 160 and 800 mg, respectively b.i.d. x 3 d (if susceptible ) OR fluoroquinolone (e.g., 300 mg ofloxacin, 400 mg norfloxacin, OR 500 mg ciprofloxacin b.i.d. x 3 d)
- Pediatric dose:TMP-SMZ, 5 and 25 mg/kg, respectively b.i.d. x 3 d
- Alternative regimen: DrugName Dosage_Duration
Peptic ulcer disease
- Peptic ulcer disease
Esophagitis
- Esophagitis